Avian pathogenic Escherichia coli (APEC) is ac ommon bacterial pathogen infecting chickens,r esulting in economic losses to the poultry industry worldwide.I np articular,APEC O1, one of the most common serotypes of APEC, is considered problematic due to its zoonotic potential. Therefore,m any attempts have been made to develop an effective vaccine against APEC O1. In fact, the lipopolysaccharide (LPS) O-antigen of APEC O1 has been shown to be apotent antigen for inducing specific protective immune responses. However,the detailed structure of the O-antigen of APEC O1 is not clear.T he present study demonstrates the first synthesis of ap entasaccharide repeating unit of LPS derived from virulent E. coli O1 and its conjugate with BSA. ELISA tests using the semi-synthetic glycoconjugate and the APEC O1 immune chicken serum revealed that the pentasaccharide is aglycotope candidate of APEC O1, with great potential as an antigen for vaccine development.